Switzerland vs Turkey: The number of people with susceptibility test result for rifampicin
Switzerland
87.3
in 2021
Turkey
87.71
in 2021
Switzerland rank
79th
Turkey rank
77th
The number of people with susceptibility test result for rifampicin over time
- Switzerland
- Turkey
How they compare
Turkey currently reports 87.71 against 87.3 in Switzerland, a difference of 0.41.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Switzerland ahead.
Switzerland ranks 79th and Turkey ranks 77th of 146 countries.
Across the 2 decades both report, Switzerland averaged higher in 1 and Turkey in 1.
Head to head by decade
| Decade | Switzerland | Turkey | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 92.97 | 86.95 | 6.02 | Switzerland |
| 2020s | 88.89 | 89.12 | 0.2321 | Turkey |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Switzerland or Turkey?
- Turkey, at 87.71 against 87.3 in Switzerland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Switzerland and Turkey?
- 0.41, with Turkey ahead.
- How many years of comparable data are there for Switzerland and Turkey?
- 5 years are reported by both, from 2017 to 2021.
- How do Switzerland and Turkey rank globally for the number of people with susceptibility test result for rifampicin?
- Switzerland ranks 79th and Turkey ranks 77th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.